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ABSTRACT 
Cardiovascular disease (CVD) continues to be the leading cause of death in the United 
States. For this reason, CVD and CVD risk factor prevention poses high public health 
significance, due to its prevalence and financial burden on society. CVD and risk factors 
prevalence as well as genetic structures are known to be different in White and African 
American populations. This indicates that genetic differences could be responsible for 
differences in disease prevalence. The purpose of this study was to examine if genotype was a 
significant predictor of CVD risk factor measurements over time using mixed modeling and 
trajectory group analysis. 
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1.0  INTRODUCTION 
1.1 CVD RISK FACTORS AND STATISTICS 
Cardiovascular disease (CVD) continues to be the leading cause of death for men and 
women in the United States, consisting of nearly every 1 in every 4 deaths (Murphy, 2013). 
Coronary heart disease, the most common type, contributes to nearly $108.9 billion in yearly 
costs to the United States (Heidenreich, 2011). For this reason, CVD and CVD risk factor 
prevention poses high public health significance. Americans with high levels of the metabolic 
syndrome components are at high risk for CVD. Metabolic syndrome is defined by the NIH as a 
group of risk factors that raises your risk for heart disease and other health problems (NIH). 
These Metabolic Syndrome risk factors include high blood pressure, high cholesterol, high 
glucose, high triglyceride, and high BMI. The CDC recognizes High blood pressure, high LDL 
cholesterol, and smoking as key risk factors for heart disease, with about 49% of the population 
having at least one of the key factors (CDC, 2011). CVD and risk factors prevalence were also 
found to be different in White and Black populations. For example, CVD age-adjusted death 
rates are 33% higher for blacks than for the overall population and the black population also has 
a higher prevalence of high blood pressure. This has been previously contributed to lack of 
health insurance and limited access to quality health care (AHA, 2014). More recently, these 
differences have also been found to be partially genetic (Halder et al., 2008, 2012). 
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1.2 GENETICS AND PREVIOUS STUDIES 
Black and white populations are also known to have different gene structures. This is 
seem both within our dataset but also validated in publically available databases. With this, it is 
possible that genetic differences could also be partially responsible for differences in disease and 
risk factor prevalence. Although blood pressure is thought to be considered highly heritable, only 
about 0.9% of phenotypic variance has been identified. This is thought to be due to specific 
interactions with inflammation, blood coagulation, cellular adhesion molecules, and lipid 
metabolism (El Shamieh, 2012). Multiple loci on chromosome 1 have been previously reported 
to be linked to blood pressure phenotypes, with fine locus mapping tracing the variation to 
ATP1B1, RGS5 and SELE genes. Polymorphisms in the SELE gene found to be associated with 
both SBP and DBP (Faruque, 2011). Although prior analysis has been performed to find 
association between inflammation genes and blood pressure measurements, to our knowledge, 
nothing has been done to look at the longitudinal effects of genotype on blood pressure. 
1.3 DATA DESCRIPTION 
For this study, data was collected longitudinally as a part of the University of Pittsburgh 
HeartSCORE Study. HeartSCORE was instituted in 2003 with hopes to explain racial and 
socioeconomic disparities in cardiovascular risk. Study subjects included 771 Whites and 464 
African Americans, between 45-74 years in age, and represented all Framingham risk strata. The 
study population was made up of approximately 64% females. The Illumina iSelect IBC Chip 
was used to genotype approximately 49k single nucleotide polymorphisms (SNPs) covering 
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approximately 2100 genes for each individual enrolled in the study. A subset containing 400 
single nucleotide polymorphisms (SNPs), in 8 inflammation and 8 serotonin pathway genes, 
were examined specifically.  These included both known functional variants and tag SNPs with 
no known functions. Metabolic risk factor measurements, systolic blood pressure (SBP), 
diastolic blood pressure (DBP), (high-density lipoprotein) HDL and (low-density lipoprotein) 
LDL Cholesterol, Triglycerides, and (body mass index) BMI measurements, as well as 
psychological risk factors, such as anxiety and depression (CES-D), were collected yearly. Risk 
factors of CVD were then examined longitudinally using group based trajectory modeling was 
used using the TRAJ procedure, developed by Jones, Nagin, and Roeder of CMU. All analysis 
was performed in SAS v. 9.3 and plink v. 1.07. 
1.4 OBJECTIVE 
The objective of this thesis was to examine if relationships exist between SNPs, located 
within the Selectin-E (SELE) gene, and longitudinal measurements blood pressure. 
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2.0  METHODOLOGY 
2.1 EXPLORATORY/UNIVARIATE ANALYSIS 
Analysis was performed separately by race. CES-D score, cholesterol levels, HDL levels, 
and triglyceride levels were all log-transformed to help with normalization prior to analysis. 
Univariate analysis was performed using ANOVAs to compare means at baseline for each 
outcome variable (diastolic BP, systolic BP, BMI, ln(CESD score), ln(cholesterol), ln(HDL), and 
ln(triglyceride levels) by genotype for all SNPs (280 inflammation and 129 serotonin SNPs). 
ANOVAs allow for the generalization of the t-test to more than two groups. The null hypothesis 
for the ANOVA is that the group means do not differ between groups. This test is based on the F 
statistics which is defined by: 
F=  
Since the grouping variable variance is in the numerator, the larger the between group variance, 
the larger the F-statistics indicating a greater likelihood that differences in mean are not due to 
chance (Agresti, 2007). 
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2.2 LINEAR REGRESSION 
Linear regression is often used when examining a continuous outcome with a number of 
independent predictors. Specific assumptions must meet in order for linear regression to be a 
valid method for data analysis. These include that there is an underlying linear relationship 
between the dependent (outcome) and independent (predictors) variables, errors resulting from 
model fitting must be uncorrelated, independent, and normally distributed, and that equal 
variances are present (homoscedasticity) (Chapman, 2001). 
Linear regression models can be represented in the following general matrix form: 
y=Xβ +ε 
 
Where y is an n x 1 vector of the outcome variable; X is an n x p matrix of the p predictor 
variables; β is a p x 1 column vector of the regression coefficients, and ε is the error (Chapman, 
2001). 
There are various model selection methods which allow for the determination of the 
inclusion of covariates; backwards, forwards, and stepwise. The backwards method involves the 
initial fitting of the full model with removal of variables sequentially, based on a cutoff p-value 
selected a priori, until all variables remain significant. The forwards method involves the 
addition of variables one at a time sequentially into the model. If the variable is significant it 
remains in the model, it the variable fails to reach the significant p-value it is removed. Lastly, 
the stepwise method allows the addition and elimination of variables in the model, dropping or 
adding variables at the various steps (Chapman, 2001). 
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For this project, covariates were preselected based on literature and backward selection 
methodology. Age, sex, socio-economic status measurement composed of education and income, 
anti-hypertensive medication usage, time, and genotype (predictor of interest) were included in 
each model as well as. BMI was also included as a covariate for blood pressure variables.  
2.3 LOGISTIC REGRESSION 
Logistic regression is often used when examining a binary outcome with a number of 
independent predictors. The general form of logistic regression model is  
 
Where  
 
P(X) is the probability of “1”, in the binary outcome, X is the list of predictors, β’s are 
parameters estimated. The logit link function for logistic regression models log(odds); therefore, 
odds can be computed for both the “0” and “1” group in order to compute an odds ratio for group 
comparisons. 
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2.4 LINK FUNCTIONS 
Link functions and families allow for the extension of mixed models for other types of 
outcome variables such as count, binary, and continuous outcomes by linking beta parameters 
estimated to real parameters (Agresti, 2007). The link function restricts the range of values of a 
particular estimate. Without the link, the estimates of the regression function can range from (-∞, 
∞) which may not necessary fit the underlying distributions (Bates, 2010). For example, binary 
outcome variables in logistic regression can only take on values of 0 or 1. 
 
Table 1. Commonly Used Link Functions 
Link Formula Domain 
Identity µ (-∞,∞) 
Log log µ (0, ∞) 
Inverse 1/ µ (0, ∞) 
Sq. root √ µ (0, ∞) 
Logit Log (µ/(1- µ)) [0,1] 
Log-log Log(-log(1- µ)) [0,1] 
Power µ
k
 (0, ∞) 
 
2.5 LONGITUDINAL MIXED MODELS 
Longitudinal studies are defined as a study which the participant is followed and data is 
collected over an extended period of time. These studies are very beneficial because they allow 
for the observation of incident events, allow for a prospective look at exposures, allow for the 
observation of individual changes in outcomes, and allow for the separation of time effects. 
Potential weaknesses of this study design are that it is strongly affected by patient follow-up. 
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This method also allows for the analysis of correlated data, as well as the introduction of more 
complex modeling due to the influence of time-varying covariates (Brown, 2006). 
Previously, alternative methodology would have been used for the analysis of 
longitudinal data such as analyzing mean response over time, analyzing the data at each time 
point, and analyzing data at all-time points with fixed subject effects. These alternative methods 
do have some disadvantages over mixed modeling. The first two approaches do not allow for the 
observation of differences over time. The fixed subject effect models, although should be 
equivalent to random subject effect model, may result in some estimation errors if there are too 
many subjects and very few time points (Brown, 2006). 
Mixed modeling was performed using the PROC MIXED procedure with a REPEATED 
statement to control for the repeated measures found in the data as well as a RANDOM 
statement to allow for the differences in intercepts seen on the spaghetti plots for each individual. 
Spaghetti plots were used as a visual tool allowing for individual trajectories to be seen over 
time. For this reason, spaghetti plots are generated to show the time course profile for each 
outcome by genotype group and race in addition to mean trajectory plots (SAS Institute Inc, 
2002). 
Mixed models for modeling longitudinal data allows for two components: a fixed and a 
random component. The fixed components are interpreted as they would be in normal linear 
regression. The random component adjustments and corrects for correlations present in the data, 
due to the repeated measurements and lack of independence of the observations.  
The general form of a mixed model is given by: 
y=Xβ+Zγ+ε 
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Where y is a n x 1 vector of the outcome variable; X is a n x p matrix of the p predictor 
variables; β is a p x 1 column vector of the fixed-effects regression coefficients; Z is the n x q 
design matrix for the q random effects; γ is a q x 1 vector of the random effects and is also 
considered the random complement to the fixed β; and ε is a n x 1 column vector of the residuals 
(Brown, 2006). 
 
The variance of Y is defined by: 
V=ZGZ’ +R 
Where R is the variance component resulting from the fixed effects, var=σ2 I, G is the variance 
component attributed to the random part of the model, and Z is the design matrix. If the variance 
of the random component is zero, G=0, the resulting model is equivalent to regular linear 
regression (Brown, 2006). 
2.6 COVARIANCE STRUCTURES 
Covariance structures were determined by running models with the various structures 
(compound symmetry, AR(1), toeplitz, and unstructured) and comparing AIC, with the model 
containing the lowest AIC selected as the best model. Inclusion of a covariance structure 
accounts for the lack of independence within the sample population, due to the repeated 
measurements. Common covariance structures include: compound symmetry (CS), Auto-
regressive 1 (AR-1), Toeplitz, and unstructured (Brown, 2006). 
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CS example: 
 
AR(1) example: 
σ2  
 
Toeplitz example: 
 
Unstructured example: 
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2.7 MODEL DIAGNOSTICS 
Model diagnostics were outputted using the VCIRY option in the PROC MIXED SAS 
procedure. This adds scaled marginal residual to output data sets and assesses model fit by 
examining departures from normality. Once adequate fit was observed, a SAS macro was created 
to examine the SNPs in the selected serotonin and inflammation pathway genes as predictors for 
the risk measurements longitudinally for all of the outcome variables. Once single locus results 
were obtained haplotypes will be generated using Haploview Tagger v.4.2 and PHASE v. 2.1 
software and the analysis was repeating using haplotypes as predictor for the longitudinal risk 
factors (Barrett, 2005). 
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3.0  RESULTS AND CONCLUSIONS 
Table 2: Baseline Population Characteristics 
Variable Gender Medication 
Use 
Age DBP BMI SES AF 
 Mean (SD) or N (%) 
Category Male Yes  
Blacks 135 
(29.1%) 
244 
(52.6%) 
58.01 
(7.34) 
82.91 
(9.95) 
32.37 
(6.59) 
-0.042 
(0.87) 
0.68 
(0.16) 
Whites 294 
(38.1%) 
251 
(32.6%) 
59.60 
(7.34) 
79.24 
(9.96) 
28.61 
(5.26) 
-0.042 
(0.84) 
 
p-value 0.001 <0.001 <0.001 <0.001 <0.001 0.921 
T-test p-values are shown for continuous variables and X
2
 p-values are shown for categorical 
variables comparing the Black and White populations. 
 
Baseline characteristics differ between Black and White populations with gender 
proportions, medication usge, age, blood pressure, and BMI. With Blacks overall having higher 
proportions of females, medication usage, DBP, and BMI but overall being slightly younger. 
There was not a statistically significant difference in the two populations in SES. Percent African 
ancestry (AF) was only examined in the Black population with an average AF of approximately 
68%. 
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Table 3: Number of observations by Time point 
Variable 
Time Point 
(years) 
Whites (N) Blacks (N) 
DBP 
Baseline 771 463 
1 734 404 
2 692 383 
3 672 372 
4 664 354 
 
Table 3 shows adequate sample size and follow-up to analyze the data longitudinally. The 
White population is larger, starting with 771 individuals, with approximately 14% loss of follow-
up between baseline and year 4 measurements. The Black population, starting with 463 
individuals, had about 24% loss of follow-up between baseline and year 4 measurements. 
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Table 4: Minor Allele Frequencies of SELE SNPs tested 
Name 
White Alleles 
(Major: Minor) 
White 
MAF 
White HWE 
p-value 
Black Alleles 
(Major: Minor) 
Black 
MAF 
Black HWE 
p-value 
rs6693963 C:G 0.148 0.613 C:G 0.112 0.572 
rs2205850 A:G 0.290 0.150 A:G 0.094 0.007 
rs3917439 C:C 0.000 1.000 C:A 0.053 0.525 
rs3917438 G:A 0.053 0.726 G:A 0.013 1.000 
rs3917437 G:A 0.001 1.000 G:A 0.058 0.391 
rs3917434 A:G 0.293 0.247 A:G 0.135 1.000 
rs3917432 T:A 0.096 1.000 T:A 0.026 0.526 
rs3917430 C:G 0.155 0.564 C:G 0.261 0.329 
rs5368 G:A 0.108 0.883 G:A 0.084 0.284 
rs1076637 G:A 0.159 0.751 G:A 0.302 0.336 
rs3917419 G:A 0.419 0.322 G:A 0.282 0.215 
rs3917415 G:C 0.001 1.000 G:C 0.094 0.755 
rs3917413 A:G 0.498 0.242 G:A 0.326 0.983 
rs3917412 G:A 0.250 0.606 G:A 0.069 0.681 
rs5361 A:C 0.111 0.759 A:C 0.033 1.000 
rs3917410 A:G 0.111 0.759 A:G 0.033 1.000 
rs727909 G:A 0.170 0.004 G:A 0.352 0.992 
rs5353 A:G 0.287 0.311 A:G 0.420 0.280 
rs3917397 A:G 0.002 1.000 A:G 0.058 0.389 
rs3917452 C:A 0.111 0.759 C:A 0.033 1.000 
rs3917392 A:G 0.109 0.958 A:G 0.033 1.000 
rs10919229 A:T 0.050 1.000 A:T 0.209 1.000 
rs7515714 G:A 0.288 0.378 G:A 0.233 0.532 
rs12408179 A:G 0.150 0.706 A:G 0.088 0.210 
 
Minor allele frequencies and HWE- p-values were calculated as part of inclusion criteria 
for SNP’s to be tested. If a SNPs MAF or HWE p-value was less than 0.05, it was excluded from 
the analysis. Four White and 6 Black SNPs were excluded based on MAF and 1 SNP for each 
race was also excluded based on HWE. 
Linkage disequilibrium plots were then visualized in HAPLOVIEW. Essentially, a heat 
map is outputted with D=1 indicated in RED with other percentages clearly marked. Grey 
indicates very low LD. From this we can see that the genetic structures differ between the two 
races which is also validated in publically available databases such as HapMap. 
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The LD plot for Blacks, pictured above, indicates that variation in SELE can be broken into one 
large block containing SNPs rs6693963-rs7515714 and rs12408179. This indicates that the 
majority of variation in this gene can be summarized by selecting one SNP from rs6693963-
rs7515714 as well as rs12408179.  
 
Figure 1: SELE Linkage disequilibrium plot for Black population 
 
 
 
 
 
 The LD plot for Whites, pictured above, indicates that variation in SELE can be summarized by 
one large haplotype block and that all SNPs tested were in very high LD. 
 
Figure 2: SELE Linkage Disequilibrium Plot in Whites 
 
Single SNP Analysis Schematic and Example: 
All SNPs which met the HWE and MAF requirement were analyzed in the same manner. 
For this reason, one example, rs5368, will be looked at in detail. This SNP was selected because 
it met inclusion criteria for both whites and blacks. It is also a coding SNP within SELE which is 
known to causes an amino acid substitution.  This SNP has not been looked at for associations 
with BP but has previously looked at its association with Multiple Sclerosis (Fenoglio, 2009) and 
SELE levels (Wu, 2012). 
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Table 5: SNP Sample Characteristics 
SNP Race Allele Counts MAF χ2 p-value 
rs5368 
Whites 
AA (8) 
AG(151) 
GG(612) 
0.108 
0.551 
Blacks 
AA (1) 
AG(76) 
GG(387) 
0.084 
χ2 p-value shows there is not a significant difference in allele frequencies between the two races. 
3.1 WHITE MIXED MODEL ANALYSIS RESULTS  
 
Figure 3: ANOVA results comparing baseline DBP by rs5368 genotype for Whites 
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ANOVA results indicate there is a difference in mean DBP at baseline between rs5368 
genotype groups (F=5.45, p=0.004). 
 Individual trajectories were then visualized for each population by genotype. Spaghetti 
plots allow for the identification of trends across time as well as the visualization of individual 
variations within the data.  
 
Figure 4: White Spaghetti Plots for DBP over time by rs5368 genotype 
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 Variation in spaghetti plots were then summarized by plotting mean trajectories of each 
genotype group. 
 
The mean trajectory plot for whites (Figure) shows differences in slope as well as intercepts for 
the three genotype groups, indicating that it is appropriate to allow for a random intercept as well 
as test for a possible interaction between genotype and the time variable (year).  
 
Figure 5: White Spaghetti Plots for DBP over time by rs5368 genotype 
 
 
Mixed univariate analysis was then performed in SAS using the PROC MIXED 
procedure with a REPEATED statement to control for the repeated measures found in the data as 
well as a RANDOM statement to allow for the differences in intercepts seen on the spaghetti 
plots for each individual. Rs5368 and time were included as predictors (Tables 8 and 13, 
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respectively). Using the models only containing the SNP and year, covariance structure were 
determined by re-running models with the various structures (compound symmetry, AR(1), 
toeplitz, and unstructured) and comparing AIC, with the model containing the lowest AIC 
selected as the best model. 
Table 6: AIC for various Univariate models with different covariance structures in 
whites 
 Covariance Structure AIC Order 
Model 1 CS 24284.8 4 
Model 2 AR(1) 24277.5 2 
Model 3 Toeplitz 24282.0 3 
Model  4 Unstructured 24155.9 1* 
For whites, an unstructured correlation structure preformed the best using AIC selection criteria 
(Table 6).  
 
Table 7: Univariate Model for DBP and rs5368 in whites 
Effect rs5368 Estimate S.E. DF P-value 
Type III test of 
Fixed Effects 
Intercept 
 
76.34 0.25 760 <.0001 
 
rs5368 11 2.55 2.20 724 0.247 
0.152 rs5368 13 0.93 0.58 770 0.106 
rs5368 33 0 . . . 
 
Since rs5368 was found to have a priori p-value < 0.20 univariately (p= 0.152), models 
were adjusted for covariates. Age, sex, socio-economic status, medication usage, year, baseline 
levels, and time varying BMI were included in each model. Backwards selection was used until 
all variables remained significant in the model.  
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Table 8: Full Model for DBP and rs5368 in whites 
Effect rs5368 year Estimate S.E. DF 
P-
value 
Type III test of 
Fixed Effects 
Intercept 
  
70.25 2.73 657 <.0001 
 
age 
  
0.01 0.04 566 0.8598 0.8598 
sex 
  
-1.55 0.52 572 0.0032 0.0032 
zses 
  
-0.48 0.32 618 0.1342 0.1342 
bmi 
  
0.37 0.04 885 <.0001 <.0001 
Antihypertensive 
medication   
1.28 0.55 578 0.0197 0.0197 
year 
 
1 -1.37 0.50 557 0.0067 
0.0339 
year 
 
2 -3.06 0.49 557 <.0001 
year 
 
3 -3.63 0.49 545 <.0001 
year 
 
4 -3.04 0.50 535 <.0001 
year 
 
0 0.00 . . . 
rs5368 11 
 
5.68 4.46 567 0.2034 
0.4087 rs5368 13 
 
0.36 1.02 569 0.7278 
rs5368 33 
 
0.00 . . . 
rs5368*year 11 1 -5.06 4.73 543 0.2855 
0.9413 
rs5368*year 11 2 -3.33 4.60 533 0.4692 
rs5368*year 11 3 -3.74 4.51 516 0.4075 
rs5368*year 11 4 -3.79 4.60 502 0.41 
rs5368*year 11 0 0.00 . . . 
rs5368*year 13 1 0.46 1.11 565 0.681 
rs5368*year 13 2 -0.34 1.08 562 0.7517 
rs5368*year 13 3 0.64 1.07 556 0.5479 
rs5368*year 13 4 0.58 1.09 546 0.5952 
rs5368*year 13 0 0.00 
   
rs5368*year 33 1 0.00 
   
rs5368*year 33 2 0.00 
   
rs5368*year 33 3 0.00 
   
rs5368*year 33 4 0.00 
   
rs5368*year 33 0 0.00 
   
The interaction term and zses were sequentially removed from the model. Age was not 
significant but was forced into the model due to its clinical significance. 
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Table 9: Final model for DBP and rs5368 in whites after backward selection 
Effect rs5368 year Estimate S.E. DF P-value 
Type III test of Fixed 
Effects 
Intercept 
  
68.90 2.27 879 <.0001 0.872 
age 
  
0.00 0.03 768 0.872 0.025 
sex 
  
-0.99 0.44 766 0.025 <.0001 
BMI 
  
0.40 0.04 1130 <.0001 <.0001 
year 
 
1 -1.93 0.38 751 <.0001 
<.0001 
year 
 
2 -2.96 0.37 746 <.0001 
year 
 
3 -3.48 0.37 738 <.0001 
year 
 
4 -3.36 0.38 722 <.0001 
year 
 
0 0.00 . . . 
rs5368 11 
 
3.04 2.05 720 0.140 
0.124 rs5368 13 
 
0.80 0.54 772 0.137 
rs5368 33 
 
0.00 . . 
 
 
 
The final model in whites contained age, gender, BMI, and year. The SNP was not statistically 
significant based on a p<0.05; however, model diagnostics indicate appropriate fit. This can be 
seen visually on the qq-plot and distribution of errors which appear to be random without any 
noticeable patterning. 
Figure 6: Model Diagnostics for Final Model rs5368 in whites 
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Mixed modeling allowed for the examination of the effect of genotype longitudinally 
over time. Analysis was then also performed to examine the effect of genotype on group 
membership of clustering within the data. Trajectory analysis was then performed using the 
PROC TRAJ procedure in SAS. Different combinations of groups and ordered models were 
tested; however, the two groupings with linear relationships were favored over the other 
grouping combinations (based on BIC).  
3.2 WHITE TRAJECTORY ANALYSIS RESULTS 
 
 
Figure 7: White DBP Group Membership 
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            The two groupings were then recoded into indicator (0=low, 1=high DBP group) and  
logistic regression was performed in Plink v1.07. 
Table 10: Univariate Logistic Results using DBP group membership as outcomes Whites 
Race SNP BP Beta OR Allele STAT P-value 
Whites rs5368 167963570 0.504 1.655 A 2.573 0.01008 
Plink outputs the effect of each extra minor allele. In the white trajectory analysis OR=1.655 
indicating that odds of being in the “high” DBP category is ~66% higher for those individuals 
with each additional A allele. 
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3.3 BLACK MIXED MODEL ANALYSIS RESULTS 
 
From Figure 7 above, we can see that only one individual has the minor/minor allele genotype. 
This would cause potential problems with the estimation and evaluation of statistical models due 
to the small sample size. For this reason, for the remaining analysis the 11 (AA) and 13 (AG) 
groups will be combined. 
 
Figure 8: ANOVA results comparing baseline DBP by rs5368 genotype for Blacks 
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ANOVA results indicate that there was not a statically significant difference in mean DBP at 
baseline for Blacks (F=0.18, P=0.673). 
Figure 9: ANOVA results comparing baseline DBP by rs5368 genotype for Blacks with AA 
and AG groups combined 
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Similarly in Blacks, spaghetti plots show variation in individual trajectories of DBP over time.  
Figure 10: Individual trajectory plots for black population using combined SNP groups 
 
 
 
Figure 11: Mean Trajectories and best fit for DBP over time by rs5368 combined 
genotype in Blacks 
AA/AG Combined GG Genotype 
 Mean time course profiles indicate a different slope and intercept between genotype 
groups. This means that mixed modeling would be appropriate which a REPEATED 
statement is used to control for the repeated measures found in the data as well as a RANDOM 
statement to allow for the differences in intercepts seen on the spaghetti plots for each individual. 
Table 11: AIC for various Univariate models with different covariance structures in blacks 
Covariance Structure AIC Order 
Model 1 CS 13711.3 4 
Model 2 AR(1) 13704.6 2 
Model 3 Toeplitz 13708.4 3 
Model  4 Unstructured 13673.8 1* 
AIC tables indicate that an unstructured correlation structure would provide a best fit for the 
correlations in the data (AIC=13673.8). 
Table 12: Univariate Model for DBP and rs5368 in blacks 
Effect rs5368 recode Estimate S.E. P-value| 
Intercept 79.256 0.345 <.0001 
rs5368 recode 11 and 13 combined 0.503 0.841 0.550 
rs5368 recode 33 0.000 
Black univariate results indicate a there was not a statistically significant association between 
rs5368 genotype recoding and DBP (p=0.550).  
Although the p-value is greater than the a-priori p-value of p=0.20, models were still 
adjusted for covariates (age, gender, zses, medication use, and bmi) in this example. Backward 
model selection was then used to systematically eliminate variables from the model, based on 
p=0.05, until all variables remained significant. 
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Table 13: Full model for DBP and rs5368 in blacks 
Effect rs5368 year Med Estimate S.E. P-value TIII p-value 
Intercept    75.268 4.281 <.0001  age    -0.033 0.052 0.529 0.529 sex    -2.516 0.807 0.002 0.002 Anti-hyp   Yes 0.410 0.750 0.585 0.585 Anti-hyp   No 0.000 . .  BMI    0.266 0.057 <.0001 <.0001 ZSES    -0.309 0.407 0.448 0.448 AF    0.399 2.326 0.864 0.864 year  1  2.686 0.627 <.0001 0.011 year  2  0.229 0.618 0.712  year  3  1.008 0.552 0.069  year  4  0.000 . .  rs5368 11 and 13 combined   1.875 1.308 0.153 0.383 rs5368 33   0.000 . .  rs5368*year 11 and 13 combined 1  -1.658 1.521 0.277 0.690 rs5368*year 11 and 13 combined 2  -1.504 1.483 0.312  rs5368*year 11 and 13 combined 3  -1.001 1.313 0.447  rs5368 *year 11 and 13 combined 4  0.000 . .   
Sex, bmi, antihypertensive medication usage, and year remained after the selection 
process. Age was forced into the model due to its clinical significance resulting in the final 
model. 
Table 14: Final model for DBP and rs5368 in Blacks after backward selection 
Effect rs5368 recode year Estimate S.E. P-value Type III 
p-value 
Intercept   77.296 3.211 <.0001  
age   -0.054 0.041 0.194 0.194 
sex   -2.715 0.673 <.0001 <.0001 
bmi   0.269 0.047 <.0001 <.0001 
year  1 2.014 0.483 <.0001 0.0002 
year  2 0.932 0.466 0.046  
year  3 1.369 0.427 0.002  
year  4 0.000 . .  
rs5368 recode 11 and 13 Combined  0.522 0.810 0.520 0.520 
rs5368 recode 33  0.000 .   
The final model in Blacks indicate that rs5368 was not a statistically significant (p=0.520) 
predictor of DBP. 
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Figure 12: Model Diagnostics for Final Model in blacks 
Model diagnosis indicated appropriate fit of the model. This can be visually observed by 
the plots of the residuals and qq-plot, which show normally distributed residuals with no visual 
patterning. Trajectory analysis was then performed using the PROC TRAJ procedure in SAS. 
Different combinations of groups and ordered models were tested; however, the two groupings 
with linear relationships were favored over the other grouping combinations (based on BIC).  
 
 
3.4 BLACK TRAJECTORY ANALYSIS RESULTS 
Figure 13: Group Trajectory Plot Blacks 
 The two groupings were then recoded into indicator (0=low, 1=high DBP group) and 
logistic regression was performed using plink v.1.07. 
Table 15: Univariate Logistic Results using DBP group membership as outcomes Blacks 
SNP BP Allele Beta OR STAT P-value 
rs5368 (Combined) 167963570 A -0.403 1.018 -1.355 0.883 
Logistic regression results indicate that the minor allele for rs5368 does not significantly effect 
odds of group membership (p=0.883). 
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4.0  DISCUSSION 
After pruning of SNPs in SELE, based on MAF=0.05 and HWE=0.05, 19 snps were 
examined in whites, and 18 snps were examined in blacks for longitudinal grouping associations 
with DBP. In whites, 6 of the 19 snps tested showed significant associations with DBP group 
membership: rs3917430, rs1076637, rs5353, rs5368, rs3917413, and rs3917432 with p-values of 
0.002, 0.002, 0.002, 0.01, 0.022, and 0.048, respectively. In blacks, only one SNP, rs3917412, 
was statistically significantly associated with group membership p=0.022. In future analysis it 
may be beneficial to combine genotype groups for snps which had very low minor/minor allele 
parings to increase power and test whether the presence or absence of the allele is influencing 
group membership. Haplotype analysis may also be helpful to try to identify if the variation in 
SELE, as a whole, may be responsible for CVD risk disparities as opposed to one SNP in the 
gene region. Multiple testing could also be accounted for by applying some sort of correction 
(FDR, Bonferoni, etc.) to decrease the type II error. 
 
 
  33 
APPENDIX A: White SELE Logistic Regression Results 
Table 16: White SELE Logistic Regression Results for Remaining SNPs 
SNP BP Allele N BETA OR STAT P-value 
rs6693963 167952069 3 576 -0.153 0.858 -0.887 0.375 
rs2205850 167958063 3 576 -0.176 0.838 -1.318 0.187 
rs3917438 167960474 1 576 0.118 1.125 0.461 0.645 
rs3917434 167961319 3 576 -0.158 0.854 -1.184 0.237 
rs3917432 167961734 1 575 0.405 1.499 1.977 0.048 
rs3917430 167962186 3 576 0.536 1.710 3.169 0.002 
rs5368 167963570 1 576 0.504 1.655 2.573 0.010 
rs1076637 167964068 1 576 0.533 1.704 3.159 0.002 
rs3917419 167966443 1 576 -0.218 0.804 -1.804 0.071 
rs3917413 167966909 3 191 0.507 1.660 2.293 0.022 
rs3917412 167967126 1 576 -0.179 0.836 -1.296 0.195 
rs5361 167967684 2 576 0.004 1.004 0.021 0.983 
rs3917410 167967732 3 576 0.004 1.004 0.021 0.983 
rs5353 167969598 3 576 0.424 1.528 3.144 0.002 
rs3917452 167970241 1 576 0.004 1.004 0.021 0.983 
rs3917392 167970959 3 549 -0.073 0.930 -0.380 0.704 
rs7515714 167974353 1 567 -0.174 0.840 -1.299 0.194 
rs12408179 167974751 3 576 -0.123 0.884 -0.716 0.474 
rs725974 168879875 2 574 0.136 1.146 0.895 0.371 
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APPENDIX B: Black SELE Logistic Regression Results 
Table 17: Black SELE Logistic Regression Results for Remaining SNPs 
SNP BP Allele N BETA OR STAT P-value 
rs6693963 167952069 G 320 0.127 1.135 0.497 0.620 
rs3917439 167960345 A 320 0.092 1.097 0.257 0.797 
rs3917437 167960645 A 319 0.577 1.780 1.683 0.092 
rs3917434 167961319 G 320 0.380 1.462 1.623 0.105 
rs3917430 167962186 G 320 0.060 1.061 0.349 0.727 
rs5368 (Combined) 167963570 A 320 -0.403 1.018 -1.355 0.883 
rs1076637 167964068 A 320 0.019 1.020 0.118 0.906 
rs3917419 167966443 A 320 -0.031 0.970 -0.163 0.870 
rs3917415 167966762 C 320 -0.489 0.613 -1.697 0.090 
rs3917413 167966909 A 134 0.154 1.167 0.608 0.543 
rs3917412 167967126 A 320 0.760 2.139 2.287 0.022 
rs727909 167968965 A 262 0.059 1.061 0.324 0.746 
rs5353 167969598 G 320 -0.103 0.902 -0.664 0.507 
rs3917397 167969808 G 320 0.570 1.769 1.665 0.096 
rs10919229 167971751 T 320 0.289 1.335 1.490 0.136 
rs7515714 167974353 A 318 -0.039 0.962 -0.206 0.837 
rs12408179 167974751 G 320 0.339 1.404 1.136 0.256 
rs725974 168879875 C 319 0.082 1.085 0.422 0.673 
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